While large-molecule therapeutics capture most headlines, small-molecule drugs face significant challenges, struggling with funding cuts, supply chain disruptions, and growing demand. At the same time ...
CINCINNATI--(BUSINESS WIRE)--National Resilience (“Resilience”), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today announced long-term debt ...
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations This financing underscores Resilience’s critical role as a CDMO manufacturing sterile drugs at scale and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results